Zoetis Inc. (NYSE:ZTS) Shares Acquired by Lyell Wealth Management LP

Lyell Wealth Management LP lifted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 3.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 55,791 shares of the company’s stock after buying an additional 1,962 shares during the quarter. Zoetis makes up about 1.3% of Lyell Wealth Management LP’s investment portfolio, making the stock its 24th largest holding. Lyell Wealth Management LP’s holdings in Zoetis were worth $11,011,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Blue Bell Private Wealth Management LLC grew its position in shares of Zoetis by 222.5% during the fourth quarter. Blue Bell Private Wealth Management LLC now owns 129 shares of the company’s stock worth $25,000 after buying an additional 89 shares in the last quarter. Moisand Fitzgerald Tamayo LLC lifted its stake in Zoetis by 105.5% during the third quarter. Moisand Fitzgerald Tamayo LLC now owns 187 shares of the company’s stock worth $33,000 after purchasing an additional 96 shares during the last quarter. Independence Bank of Kentucky lifted its stake in Zoetis by 371.4% during the fourth quarter. Independence Bank of Kentucky now owns 165 shares of the company’s stock worth $33,000 after purchasing an additional 130 shares during the last quarter. Ramirez Asset Management Inc. bought a new position in Zoetis during the third quarter worth $35,000. Finally, First Financial Corp IN lifted its stake in Zoetis by 57.2% during the fourth quarter. First Financial Corp IN now owns 217 shares of the company’s stock worth $43,000 after purchasing an additional 79 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Ratings Changes

ZTS has been the topic of a number of recent research reports. Barclays cut their target price on Zoetis from $260.00 to $230.00 and set an “overweight” rating on the stock in a research note on Tuesday. Stifel Nicolaus cut their target price on Zoetis from $215.00 to $195.00 and set a “buy” rating on the stock in a research note on Tuesday, April 2nd. StockNews.com cut shares of Zoetis from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, February 20th. Piper Sandler restated an “overweight” rating and set a $195.00 price objective (down from $220.00) on shares of Zoetis in a research note on Tuesday, April 16th. Finally, The Goldman Sachs Group lifted their price objective on shares of Zoetis from $190.00 to $226.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. Eight equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $218.00.

Zoetis Price Performance

NYSE:ZTS traded up $1.33 during mid-day trading on Wednesday, reaching $150.89. 3,640,337 shares of the stock were exchanged, compared to its average volume of 3,074,906. The business has a fifty day moving average price of $173.11 and a 200 day moving average price of $179.58. The firm has a market capitalization of $69.01 billion, a PE ratio of 29.76, a PEG ratio of 2.22 and a beta of 0.85. Zoetis Inc. has a 1-year low of $144.80 and a 1-year high of $201.92. The company has a current ratio of 3.36, a quick ratio of 2.00 and a debt-to-equity ratio of 1.32.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, February 13th. The company reported $1.24 earnings per share for the quarter, missing analysts’ consensus estimates of $1.32 by ($0.08). Zoetis had a return on equity of 51.25% and a net margin of 27.43%. The company had revenue of $2.21 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same period in the prior year, the business posted $1.15 EPS. The company’s revenue for the quarter was up 8.5% compared to the same quarter last year. Research analysts expect that Zoetis Inc. will post 5.79 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 4th. Shareholders of record on Friday, April 19th will be paid a dividend of $0.432 per share. The ex-dividend date is Thursday, April 18th. This represents a $1.73 annualized dividend and a yield of 1.15%. Zoetis’s dividend payout ratio (DPR) is presently 34.12%.

Insider Buying and Selling at Zoetis

In other Zoetis news, EVP Roxanne Lagano sold 363 shares of Zoetis stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $197.74, for a total transaction of $71,779.62. Following the transaction, the executive vice president now owns 20,417 shares of the company’s stock, valued at approximately $4,037,257.58. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders have sold a total of 2,209 shares of company stock valued at $371,293 in the last 90 days. 0.15% of the stock is currently owned by corporate insiders.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.